Cardiff Oncology, Inc.
A clinical-stage biotech company developing experimental cancer drugs, headquartered in San Diego. Its lead candidate, onvansertib, is an oral pill being tested against RAS-mutated metastatic colorectal cancer and other hard-to-treat tumors. The company began life in 2002 as a Florida shell company called Used Kar Parts, then rebranded as Xenomics, Trovagene, and finally Cardiff Oncology in 2020, when it set its sights on "turning the tide on cancer."
Bought 914.6K
Granted 28.9K · Bought 15.0K
Bought 67.7K
Bought 24.7K
Bought 10.0K
Bought 20.0K
Bought 13.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Pace Gary WDirector · 9 transactions | — | 4.03M | — | 914.6K | — |
| White LaleDirector · 2 transactions | +62.7% | 113.8Kas of Sep 2022 | 28.9K | 15.0K | — |
| Levine James E.Chief Financial Officer · 9 transactions | — | 67.7Kas of Dec 2024 | — | 67.7K | — |
| Mohindru ManiChief Executive Officer, Director · 1 transaction | — | 24.7K | — | 24.7K | — |
| Erlander MarkChief Executive Officer, Director · 1 transaction | +69.1% | 24.5Kas of Nov 2022 | — | 10.0K | — |
| Tannenbaum Renee PDirector · 3 transactions | — | 20.0Kas of Dec 2024 | — | 20.0K | — |
| Armitage James ODirector · 1 transaction | — | 13.0Kas of Sep 2022 | — | 13.0K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: +1.06M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.